Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling

Chezi Ganzel, Zhuoxin Sun, Timour Baslan, Yanming Zhang, Mithat Gönen, Omar I. Abdel-Wahab, Janis Racevskis, Francine Garrett-Bakelman, Scott W. Lowe, Hugo F. Fernandez, Rhett Ketterling, Selina M. Luger, Mark Litzow, Hillard M. Lazarus, Jacob M. Rowe, Martin S. Tallman, Ross L. Levine, Elisabeth Paietta